EP3413894
Notkun á hindrum með virkni eða verkun PI3K við meðhöndlun á frumkomnum Sjögrens-heilkennum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.2.2017EP published:
11.3.2020EP application number:
17704548.1
EP translation filed:
10.6.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
9.2.2037Expiry date:
9.2.2027Next due date:
28.2.2027
Title:
USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K FOR THE TREATMENT OF PRIMARY SJÖGREN'S SYNDROME
Timeline
Today
10.2.2017EP application
11.3.2020EP Publication
10.6.2020Translation submitted
15.7.2020Registration published
9.2.2027Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BIETH, BrunoAddress:
4002 Basel, CH
Name:
BURKHART, ChristophAddress:
4002 Basel, CH
Name:
CHRIST, AndreasAddress:
4002 Basel, CH
Name:
DE BUCK, StefanAddress:
4002 Basel, CH
Name:
KALIS, ChristophAddress:
4002 Basel, CH
Name:
LINDGREN, SamAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16155123Date:
10.2.2016Country:
EP
Number:
16186188Date:
29.8.2016Country:
EP
Classification
Categories:
A61K 31/519, A61P 37/00, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 28.2.2021
Expires: 9.2.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 24.2.2022
Expires: 9.2.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 22.2.2023
Expires: 9.2.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 29.2.2024
Expires: 9.2.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 4.3.2025
Expires: 9.2.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.2.2026
Expires: 9.2.2027
Payer: Árnason Faktor ehf.